Granite Point Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
2019
Q2
$422K Buy
2015
Q4
$2.97M Buy
2015
Q2
Sell
2015
Q1
$674K Hold
2014
Q4
$1.12M Sell
2014
Q3
$989K Hold
2014
Q2
$1.08M Sell
2014
Q1
$2.2M Sell
2013
Q4
$1.64M Buy